Vestal Point Capital »

Mind Medicine Mindmed shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Mind Medicine Mindmed (MNMD) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Mind Medicine Mindmed

Tip: Access up to 7 years of quarterly data

All positions including Mind Medicine Mindmed held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mind Medicine Mindmed by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.5M 637k 13.39

More positions owned by Vestal Point Capital

Abivax SA Sponsored Ads (ABVX)
Invesco QQQ Trust Series 1 Unit Ser 1 Put Option (QQQ)
Arcellx Common Stock (ACLX)
Terns Pharmaceuticals (TERN)
BioMarin Pharmaceutical (BMRN)
Globus Medical Cl A (GMED)
Nurix Therapeutics (NRIX)
Alcon Ord Shs (ALC)
Dex (DXCM)
Merck & Co (MRK)
Taysha Gene Therapies Com Shs (TSHA)
Abbott Laboratories (ABT)
Immatics NV SHS (IMTX)
Tyra Biosciences (TYRA)
Bicara Therapeutics (BCAX)

View all positions for Vestal Point Capital

Top funds holding Mind Medicine Mindmed

BlackRock
venBio Select Advisor
Driehaus Capital Management
Blackstone Group
Vanguard Group
State Street Corporation
Geode Capital Management
Octagon Capital Advisors
Commodore Capital
Deep Track Capital
OrbiMed Advisors
Susquehanna International
Candriam Luxembourg S.C.A.
Goldman Sachs Group
Charles Schwab Investment Management

View all funds holding Mind Medicine Mindmed